<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03257254</url>
  </required_header>
  <id_info>
    <org_study_id>BTG-001652-01</org_study_id>
    <nct_id>NCT03257254</nct_id>
  </id_info>
  <brief_title>Effect of VarIthena on Wound Healing in VLU</brief_title>
  <acronym>VIEW-VLU</acronym>
  <official_title>Observational Study of the Effect of VarIthena® on Wound Healing in the Treatment of Venous Leg Ulcers Resulting From Chronic Venous Insufficiency</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Provensis Ltd</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Provensis Ltd</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>Yes</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>Yes</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      12 month, multicenter, open-label registry to observe chronic venous insufficiency resulting
      in VLU treated with Varithena
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This 12 month, multicenter, open-label registry is designed to collect treatment and outcome
      data related to subjects treated with Varithena for GSV system and/or AASV incompetence
      resulting in VLU. Subjects are treated per Investigator's SoC and in accordance with the FPI
      and IFU. For subjects with healed ulcers during the 12 month follow-up period, VLU recurrence
      information is collected.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">September 29, 2017</start_date>
  <completion_date type="Anticipated">July 2021</completion_date>
  <primary_completion_date type="Anticipated">July 2020</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <target_duration>12 Months</target_duration>
  <primary_outcome>
    <measure>Epithelial migration measured by change in perimeter of wound</measure>
    <time_frame>Weekly up to wound closure or 12 months, whichever occurs first</time_frame>
    <description>Decrease in wound perimeter per week</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Wound closure rate</measure>
    <time_frame>at 12 weeks</time_frame>
    <description>Number of healed wounds at 12 weeks post treatment</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Time to wound closure</measure>
    <time_frame>Weekly up to wound closure or 12 months, whichever occurs first</time_frame>
    <description>Mean number of week to wound closure</description>
  </primary_outcome>
  <enrollment type="Anticipated">200</enrollment>
  <condition>Venous Leg Ulcer</condition>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Varithena</intervention_name>
    <description>Administration procedures and volume are per standard of care, full prescribing information, and instructions for use.</description>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patients classified C6 on CEAP classification with active VLU resulting from venous
        insufficiency of the GSV system and/or AASV
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Men and women; age ≥18

          -  Investigator has selected Varithena® to treat patients classified C6 with chronic (≥ 3
             months) VLU resulting from GSV and/or AASV incompetence

          -  Wound can be visualized in one plane to allow for image collection of the entire wound
             in one photograph, or if wound is circumferential, subject must be able to capture the
             entire wound using multiple photographs taken from directly above the wound (straight
             on)

          -  Reflux &gt;500ms on duplex ultrasound

          -  Willing and able to collect wound photographs and data using an application installed
             on a tablet

          -  Willing and able to return for scheduled follow-up and wound care visits

          -  Ability to comprehend and sign informed consent form (ICF) and complete questionnaires

        Exclusion Criteria:

          -  Contraindications to Varithena® 1% in accordance with the FPI

          -  Any serious concomitant disease, per physician's discretion, that confounds wound
             healing, including malignant changes of wound

          -  Concomitant heat ablation, or heat ablation of index leg within 6 weeks prior to
             treatment with Varithena®

          -  Significant arterial disease or ankle-brachial pressure index (ABPI) ≤ 0.8

          -  In the opinion of Investigator, wound would close within 12 weeks without additional
             treatment
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
  </eligibility>
  <overall_official>
    <last_name>Michael Shao, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Swedish Covenant Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Michael Shao, MD</last_name>
    <phone>773-781-6352</phone>
    <email>MShao@schosp.org</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Leslie Cass, MA</last_name>
    <phone>425-415-3186</phone>
    <email>leslie.cass@btgplc.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Coastal Heart Medical Group</name>
      <address>
        <city>Santa Ana</city>
        <state>California</state>
        <zip>92704</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Manu Dhawan</last_name>
      <phone>714-486-3145</phone>
      <email>mdhawan@nicresearch.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>The Vascular Experts</name>
      <address>
        <city>Darien</city>
        <state>Connecticut</state>
        <zip>06820</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Maria Myslinski</last_name>
      <phone>203-956-6834</phone>
      <email>mmyslinski@thevascularexperts.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Pines Clinical Research</name>
      <address>
        <city>Aventura</city>
        <state>Florida</state>
        <zip>33180</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jenifer Varon</last_name>
      <phone>305-792-0555</phone>
      <email>pcrjvaron@aol.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Emory University Hospital</name>
      <address>
        <city>Atlanta</city>
        <state>Georgia</state>
        <zip>30306</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Kimi Wang</last_name>
      <phone>404-712-7665</phone>
      <email>kimi.wang@emoryhealthcare.org</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Swedish Covenant Hospital</name>
      <address>
        <city>Chicago</city>
        <state>Illinois</state>
        <zip>60625</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Michael Shao, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Mass General, Boston</name>
      <address>
        <city>Boston</city>
        <state>Massachusetts</state>
        <zip>02114</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Tara Bresnahan</last_name>
      <phone>617-643-2731</phone>
      <email>tbresnahan2@mgh.harvard.edu</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>The Venous Institute of Buffalo</name>
      <address>
        <city>Buffalo</city>
        <state>New York</state>
        <zip>14226</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Kristina Morrison</last_name>
      <phone>716-877-7000</phone>
      <email>kristinamorrison@venousinstitute.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Weill Cornell Vein Treatment</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10065</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Irina Lipai</last_name>
      <phone>212-746-2528</phone>
      <email>irl2004@med.cornell.edu</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Mercy Health Cincinnati -West Hospital</name>
      <address>
        <city>Cincinnati</city>
        <state>Ohio</state>
        <zip>45211</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Cendi Kegli</last_name>
      <phone>513-952-5104</phone>
      <email>crkegley@mercy.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>OhioHealth Research</name>
      <address>
        <city>Columbus</city>
        <state>Ohio</state>
        <zip>43214</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jodie Carter Ohl</last_name>
      <phone>614-788-3866</phone>
      <email>jodie.carter-ohl@ohiohealth.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Totality</name>
      <address>
        <city>Oklahoma City</city>
        <state>Oklahoma</state>
        <zip>73118</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Steve Bernhardt</last_name>
      <phone>405-739-6596</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>University of Texas Health Sciences Center at Houston</name>
      <address>
        <city>Houston</city>
        <state>Texas</state>
        <zip>77030</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Juan Umana Pizano</last_name>
      <phone>713-512-7203</phone>
      <email>Juan.B.Umana@uth.tmc.edu</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Lake Washington Vascular, PLLC</name>
      <address>
        <city>Bellevue</city>
        <state>Washington</state>
        <zip>98004</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Krissa Gunderson</last_name>
      <phone>425-732-5958</phone>
      <email>krissag@lkwv.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Oakville Vascular</name>
      <address>
        <city>Oakville</city>
        <state>Ontario</state>
        <zip>L6J7S2</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Beverly Chan, MD</last_name>
      <email>drchan@oakvillevascular.com</email>
    </contact>
  </location>
  <location_countries>
    <country>Canada</country>
    <country>United States</country>
  </location_countries>
  <verification_date>April 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>August 16, 2017</study_first_submitted>
  <study_first_submitted_qc>August 17, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">August 22, 2017</study_first_posted>
  <last_update_submitted>April 16, 2018</last_update_submitted>
  <last_update_submitted_qc>April 16, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">April 18, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>GSV</keyword>
  <keyword>AASV</keyword>
  <keyword>Vein</keyword>
  <keyword>Venous</keyword>
  <keyword>Ulcer</keyword>
  <keyword>Vericose Vein</keyword>
  <keyword>VLU</keyword>
  <keyword>venous insufficiency</keyword>
  <keyword>venous disease</keyword>
  <keyword>chronic VLU</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Ulcer</mesh_term>
    <mesh_term>Leg Ulcer</mesh_term>
    <mesh_term>Venous Insufficiency</mesh_term>
    <mesh_term>Varicose Ulcer</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Polidocanol</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

